"Novel Methods and Emerging Targets in Drug Discovery & Patented Drug Development"
The workshop will be held on 12th October at the BAU Göztepe Campus, İstanbul.
The congress will be held on 13-15 October at the BAU Beşiktaş Campus, İstanbul.
Dimensions of the posters are 70*100
There will be a session called "The Role of Patents at the Drug Development" at the Congress by Dr. Cahit Suluk and Mr. Pinar Bulut.
Prof. David L. Selwood from UCL is attending to the Congress!!
Prof. Shaker Mousa from Albany University is attending to the Congress as Keynote Speaker!!
Prof. Chas Bountra from Oxford University is attending to the Congress as Keynote Speaker!!
Congress Start Date
October 13, 2016
Congress Location
Istanbul - TURKEY
Bahcesehir University


Dear Colleagues,

It is my pleasure and honor to host the “4th International Bahçeşehir University (BAU) Drug Design Congress” at the BAU, School of Medicine, in Istanbul. It will bring together renowned industrial and academic experts to further discuss the recent developments and advances in the drug design field.

The main theme of the BAU-Drug Design 2016 Congress will be “Recent Developments in Structure- and Ligand-based Drug Design Methodologies,” which will cover a wide range of critically important topics such as:

  • Novel Applications in Cancer Therapy
  • Synthesis of small organic molecules
  • From Bench to Clinical Applications
  • Drug Targets
  • Rare Diseases
  • Peptide Synthesis
  • Drug/Membrane Interactions
  • Potential Drug Carrier Systems
  • Design and applications of Bio-Probes in diagnosis, cell recognition and monitoring
  • Gene Network Analysis
  • Experimental techniques for Drug-Protein interactions
  • Molecular Simulations  
  • NMR-Supported Structural Biology of Drug Targets
  • Stem Cells
  • Molecular Modeling
  • Molecular Docking and Molecular Dynamics (MD) Simulations
  • De Novo Drug Design
  • Analysis of Protein/Protein and Drug/Protein Interactions
  • High Throughput Screening Methods
  • Pharmacophore Modeling
  • Structural Bioinformatics
  • Fragment-based Design
  • ADME/Tox
  • Protein Flexibility and Dynamics
  • High Performance Computing
  • Virtual Screening of Large number of small molecules

The congress aims to serve as a platform for interaction among leading experimental and computational scientists from academia and industry to discuss the latest developments in methodology, application and approaches in the drug design field and to accelerate scientific discovery as well as reflect the key goals of the strategic priorities of the university: Integration, inter-disciplinary research on basic health sciences.

I look forward to welcoming the participants to this exciting congress in the magical city of Istanbul in October 2016.

Sincerely Yours,

Assoc. Prof. Dr. Serdar DURDAGI
Chairman of the Congress
This page has been visited             times.
Arkadyas Bilişim Hizmetleri
Copyright © 2016 Tüm Hakları Saklıdır